4.7 Article

Cyclin C Regulates Human Hematopoietic Stem/Progenitor Cell Quiescence

期刊

STEM CELLS
卷 28, 期 2, 页码 308-317

出版社

WILEY
DOI: 10.1002/stem.270

关键词

Cyclin C; Hematopoietic stem/progenitor cell; Human cord blood CD34(+) cells; Quiescence; Engraftment

资金

  1. NIH [DK52208]
  2. Leukemia and Lymphoma Society SCOR
  3. JSPS [20790672]
  4. Kitamura Hematology Foundation
  5. Grants-in-Aid for Scientific Research [20790672] Funding Source: KAKEN

向作者/读者索取更多资源

Hematopoietic stem cells (HSCs) can remain quiescent or they can enter the cell cycle, and either self-renew or differentiate. Although cyclin C and cyclin dependent kinase (cdk3) are essential for the transition from the G(0) to the G(1) phase of the cell cycle in human fibroblasts, the role of cyclin C in hematopoietic stem/progenitor cells (HSPCs) is not clear. We have identified an important role of cyclin C (CCNC) in regulating human HSPC quiescence, as knocking down CCNC expression in human cord blood CD34(+) cells resulted in a significant increase in quiescent cells that maintain CD34 expression. CCNC knockdown also promotes in vitro HSPC expansion and enhances their engraftment potential in sublethally irradiated immunodeficient mice. Our studies establish cyclin C as a critical regulator of the G(0)/G(1) transition of human HSPCs and suggest that modulating cyclin C levels may be useful for HSC expansion and more efficient engraftment. STEM CELLS 2010;28:308-317

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Hematology

Calreticulin haploinsufficiency augments stem cell activity and is required for onset of myeloproliferative neoplasms in mice

Kotaro Shide, Takuro Kameda, Ayako Kamiunten, Yoshinori Ozono, Yuki Tahira, Takako Yokomizo-Nakano, Sho Kubota, Masaya Ono, Kazuhiko Ikeda, Masaaki Sekine, Keiichi Akizuki, Kenichi Nakamura, Tomonori Hidaka, Yoko Kubuki, Hisayoshi Iwakiri, Satoru Hasuike, Kenji Nagata, Goro Sashida, Kazuya Shimoda

Article Oncology

PRC2 insufficiency causes p53-dependent dyserythropoiesis in myelodysplastic syndrome

Kazumasa Aoyama, Daisuke Shinoda, Emi Suzuki, Yaeko Nakajima-Takagi, Motohiko Oshima, Shuhei Koide, Ola Rizq, Sha Si, Shiro Tara, Goro Sashida, Atsushi Iwama

Summary: Deletion of Ezh1 and Ezh2 leads to PRC2 insufficiency, causing dyserythropoiesis and activating the p53 pathway by de-repressing the Cdkn2a gene, contributing to disease progression. Rescuing dyserythropoiesis can be achieved by deleting Cdkn2a and p53.

LEUKEMIA (2021)

Article Biochemistry & Molecular Biology

Overexpression of Hmga2 activates Igf2bp2 and remodels transcriptional program of Tet2-deficient stem cells in myeloid transformation

Jie Bai, Takako Yokomizo-Nakano, Sho Kubota, Yuqi Sun, Akinori Kanai, Mihoko Iimori, Hironori Harada, Atsushi Iwama, Goro Sashida

Summary: High Mobility Group AT-hook 2 (HMGA2) is found to be overexpressed in patients with myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), with its expression level finely tuned by Lin28b-Let-7 axis and Polycomb Repressive Complex 2. The overexpression of HMGA2 can activate the oncogene Igf2bp2 and enhance self-renewal of Tet2-deficient stem cells, affecting the transcriptional program and differentiation of myeloid cells. These findings highlight the potential therapeutic target of HMGA2-Igf2bp2 axis in the transformation of stem cells.

ONCOGENE (2021)

Review Hematology

Two faces of RUNX3 in myeloid transformation

Takako Yokomizo-Nakano, Goro Sashida

Summary: RUNX3, known as a tumor suppressor in various cancers, has been found to have an oncogenic function in myeloid malignancies. Although deletions and loss-of-function mutations in RUNX3 are rare in hematopoietic malignancies, its overexpression can lead to malignant transformation.

EXPERIMENTAL HEMATOLOGY (2021)

Article Cell Biology

Inflammation-driven senescence-associated secretory phenotype in cancer-associated fibroblasts enhances peritoneal dissemination

Tadahito Yasuda, Mayu Koiwa, Atsuko Yonemura, Keisuke Miyake, Ryusho Kariya, Sho Kubota, Takako Yokomizo-Nakano, Noriko Yasuda-Yoshihara, Tomoyuki Uchihara, Rumi Itoyama, Luke Bu, Lingfeng Fu, Kota Arima, Daisuke Izumi, Shiro Iwagami, Kojiro Eto, Masaaki Iwatsuki, Yoshifumi Baba, Naoya Yoshida, Hiroto Ohguchi, Seiji Okada, Keisuke Matsusaki, Goro Sashida, Akiko Takahashi, Patrick Tan, Hideo Baba, Takatsugu Ishimoto

Summary: In the tumor microenvironment, senescent cancer-associated fibroblasts (CAFs) play a role in promoting gastric cancer (GC) peritoneal tumor formation through maintenance of the senescence-associated secretory phenotype (SASP) and JAK/STAT3 signaling. Single-cell mass cytometry analysis revealed a high expression level of senescent fibroblasts and SASP factors in the ascites of GC patients. These findings provide insights into the molecular mechanisms of inflammation-related SASP maintenance and the involvement of senescent CAFs in GC peritoneal dissemination.

CELL REPORTS (2021)

Review Oncology

Epithelial-Mesenchymal Transition in Liver Fluke-Induced Cholangiocarcinoma

Kanlayanee Sawanyawisuth, Goro Sashida, Guojun Sheng

Summary: This review summarizes the mechanisms of parasitic infection in the pathogenesis of bile duct cancer, focusing on the effects of epithelial-mesenchymal transition (EMT) in bile duct epithelial cells and its association with epigenetic dysregulation. It suggests that both direct and indirect mechanisms underlie the parasitic infection-induced EMT in cholangiocarcinoma (CCA).

CANCERS (2021)

Article Oncology

Insufficiency of non-canonical PRC1 synergizes with JAK2V617F in the development of myelofibrosis

Daisuke Shinoda, Yaeko Nakajima-Takagi, Motohiko Oshima, Shuhei Koide, Kazumasa Aoyama, Atsunori Saraya, Hironori Harada, Bahityar Rahmutulla, Atsushi Kaneda, Kiyoshi Yamaguchi, Yoichi Furukawa, Haruhiko Koseki, Kazuya Shimoda, Tomoaki Tanaka, Goro Sashida, Atsushi Iwama

Summary: The insufficiency of PRC1.1, a component of polycomb repressive complex 1, promotes the development of myelofibrosis and acts as a tumor suppressor in this process. This impact is distinct from the effect of PRC2 insufficiency on the pathogenesis of myelofibrosis.

LEUKEMIA (2022)

Letter Oncology

RUNX1-ETO (RUNX1-RUNX1T1) induces myeloid leukemia in mice in an age-dependent manner

Mohamed Gaber Abdallah, Akiko Niibori-Nambu, Mariko Morii, Takako Yokomizo, Tomomasa Yokomizo, Takako Ideue, Sho Kubota, Vania Swee Imm Teoh, Michelle Meng Huang Mok, Chelsia Qiuxia Wang, Abdellah Ali Omar, Kenji Tokunaga, Eisaku Iwanaga, Masao Matsuoka, Norio Asou, Naomi Nakagata, Kimi Araki, Mabrouk AboElenin, Sayed Hamada Madboly, Goro Sashida, Motomi Osato

LEUKEMIA (2021)

Article Hematology

The acidic domain of Hmga2 and the domain's linker region are critical for driving self-renewal of hematopoietic stem cell

Yuqi Sun, Sho Kubota, Mihoko Iimori, Ai Hamashima, Haruka Murakami, Jie Bai, Mariko Morii, Takako Yokomizo-Nakano, Motomi Osato, Kimi Araki, Goro Sashida

Summary: This study reveals the critical role of the acidic domain and linker region of Hmga2 in modulating the transcription and self-renewal functions of hematopoietic stem cells.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2022)

Article Biochemistry & Molecular Biology

ATP citrate lyase controls hematopoietic stem cell fate and supports bone marrow regeneration

Terumasa Umemoto, Alban Johansson, Shah Adil Ishtiyaq Ahmad, Michihiro Hashimoto, Sho Kubota, Kenta Kikuchi, Haruki Odaka, Takumi Era, Daisuke Kurotaki, Goro Sashida, Toshio Suda

Summary: By studying the mitochondrial metabolism and ATP citrate lyase (ACLY) in hematopoietic stem cells (HSCs), we have gained new insights into the regulation of HSCs during hematopoietic regeneration.

EMBO JOURNAL (2022)

Article Biochemistry & Molecular Biology

HMGN3 represses transcription of epithelial regulators to promote migration of cholangiocarcinoma in a SNAI2-dependent manner

Supannika Sorin, Sho Kubota, Sofiane Hamidi, Takako Yokomizo-Nakano, Kulthida Vaeteewoottacharn, Sopit Wongkham, Sakda Waraasawapati, Chawalit Pairojkul, Jie Bai, Mariko Morii, Guojun Sheng, Kanlayanee Sawanyawisuth, Goro Sashida

Summary: This study found that the high expression of high mobility group nucleosome-binding protein 3 (HMGN3) is correlated with the metastasis of cholangiocarcinoma (CCA). HMGN3 inhibits the expression of epithelial regulator genes by binding with the transcription factor SNAI2 and regulating histone deacetylases (HDACs), thereby affecting the migration capacity of CCA cells.

FASEB JOURNAL (2022)

Article Biology

CARD11 mutation and HBZ expression induce lymphoproliferative disease and adult T-cell leukemia/lymphoma

Takuro Kameda, Kotaro Shide, Ayako Kamiunten, Yasunori Kogure, Daisuke Morishita, Junji Koya, Yuki Tahira, Keiichi Akizuki, Takako Yokomizo-Nakano, Sho Kubota, Kosuke Marutsuka, Masaaki Sekine, Tomonori Hidaka, Yoko Kubuki, Yuichi Kitai, Tadashi Matsuda, Akinori Yoda, Takayuki Ohshima, Midori Sugiyama, Goro Sashida, Keisuke Kataoka, Seishi Ogawa, Kazuya Shimoda

Summary: The study investigates the oncogenic ability of mutant CARD11 (E626K), one of the most frequently mutated genes in adult T-cell leukemia, and its cooperative effect with HBZ expression. Using a mouse model, the researchers clarify the pathogenetic effects of these genes and find that they cooperatively activate multiple signaling pathways, promoting the development of ATL.

COMMUNICATIONS BIOLOGY (2022)

Article Oncology

A gain-of-function mutation in microRNA 142 is sufficient to cause the development of T-cell leukemia in mice

Shingo Kawano, Kimi Araki, Jie Bai, Imari Furukawa, Keigo Tateishi, Kumiko Yoshinobu, Shingo Usuki, Rachael A. Nimmo, Tadashi Kaname, Masaharu Yoshihara, Satoru Takahashi, Goro Sashida, Masatake Araki

Summary: miR-142 mutation plays a crucial role in blood cancers, causing a loss of function in half of the wild-type miR-142-3p alleles and gaining the function to suppress the expression of specific target genes, sufficient to induce leukemogenesis in mice.

CANCER SCIENCE (2023)

Article Immunology

Exposure to microbial products followed by loss of Tet2 promotes myelodysplastic syndrome via remodeling HSCs

Takako Yokomizo-Nakano, Ai Hamashima, Sho Kubota, Jie Bai, Supannika Sorin, Yuqi Sun, Kenta Kikuchi, Mihoko Iimori, Mariko Morii, Akinori Kanai, Atsushi Iwama, Gang Huang, Daisuke Kurotaki, Hitoshi Takizawa, Hirotaka Matsui, Goro Sashida

Summary: Prior infection stress and loss of Tet2 gene can remodel the transcriptional and epigenetic landscapes and cellular functions in hematopoietic stem cells (HSCs) via the Trif-Plk-Elf1 axis and drive the development of myelodysplastic syndrome (MDS). Pharmacological inhibition of Plk function or knockdown of Elf1 expression can prevent epigenetic remodeling in HSCs and alleviate clonogenicity enhancement and impaired erythropoiesis. Additionally, the Elf1-target signature is significantly enriched in MDS HSPCs in humans.

JOURNAL OF EXPERIMENTAL MEDICINE (2023)

Article Multidisciplinary Sciences

Overexpression of HMGN3 nucleosome binding protein is associated with tumor invasion and TGF-? expression in cholangiocarcinoma

Supannika Sorin, Nongnapas Pokaew, Kulthida Vaeteewoottacharn, Sakda Waraasawapati, Chawalit Pairojkul, Goro Sashida, Kanlayanee Sawanyawisuth

Summary: This study investigated the expression of HMGN proteins in cholangiocarcinoma (CCA) and found that HMGN3 is abnormally expressed in CCA tissues. Further analysis revealed a correlation between high HMGN3 expression and tumor invasion in CCA patients, as well as a positive correlation between HMGN3 and transforming growth factor-β expression in CCA tissues.

SCIENCEASIA (2022)

暂无数据